MANKIND PHARMA
|
MANKIND PHARMA Last 5 Year Income Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹9,106 Cr | ₹8,071 Cr | ₹6,466 Cr | ₹6,101 Cr | ₹4,980 Cr |
Sales | ₹9,083 Cr | ₹8,067 Cr | ₹6,464 Cr | ₹6,092 Cr | ₹4,969 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹23 Cr | ₹3.46 Cr | ₹2.52 Cr | ₹1.56 Cr | ₹5.71 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | - | - | - | ₹6.82 Cr | ₹5.13 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹8,749 Cr | ₹7,782 Cr | ₹6,214 Cr | ₹5,872 Cr | ₹4,980 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹291 Cr | ₹-450 Cr | ₹-247 Cr | ₹-10 Cr | ₹12 Cr |
Raw Material Consumed | ₹2,623 Cr | ₹2,871 Cr | ₹2,028 Cr | ₹1,889 Cr | ₹1,709 Cr |
Opening Raw Materials | ₹399 Cr | ₹284 Cr | ₹249 Cr | ₹160 Cr | ₹127 Cr |
Purchases Raw Materials | ₹1,829 Cr | ₹2,173 Cr | ₹1,407 Cr | ₹1,370 Cr | ₹982 Cr |
Closing Raw Materials | ₹414 Cr | ₹399 Cr | ₹284 Cr | ₹233 Cr | ₹177 Cr |
Other Direct Purchases / Brought in cost | ₹809 Cr | ₹814 Cr | ₹655 Cr | ₹591 Cr | ₹777 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹109 Cr | ₹103 Cr | ₹83 Cr | ₹80 Cr | ₹64 Cr |
Electricity & Power | ₹109 Cr | ₹103 Cr | ₹83 Cr | ₹80 Cr | ₹64 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹1,918 Cr | ₹1,621 Cr | ₹1,416 Cr | ₹1,336 Cr | ₹1,095 Cr |
Salaries, Wages & Bonus | ₹1,788 Cr | ₹1,515 Cr | ₹1,330 Cr | ₹1,271 Cr | ₹1,037 Cr |
Contributions to EPF & Pension Funds | ₹89 Cr | ₹74 Cr | ₹59 Cr | ₹43 Cr | ₹39 Cr |
Workmen and Staff Welfare Expenses | ₹22 Cr | ₹15 Cr | ₹12 Cr | ₹8.94 Cr | ₹7.76 Cr |
Other Employees Cost | ₹20 Cr | ₹17 Cr | ₹15 Cr | ₹12 Cr | ₹11 Cr |
Other Manufacturing Expenses | ₹151 Cr | ₹160 Cr | ₹140 Cr | ₹109 Cr | ₹85 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹39 Cr | ₹37 Cr | ₹27 Cr | ₹25 Cr | ₹16 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹112 Cr | ₹124 Cr | ₹113 Cr | ₹84 Cr | ₹69 Cr |
General and Administration Expenses | ₹966 Cr | ₹656 Cr | ₹452 Cr | ₹439 Cr | ₹508 Cr |
Rent , Rates & Taxes | ₹132 Cr | ₹84 Cr | ₹59 Cr | ₹61 Cr | ₹60 Cr |
Insurance | ₹15 Cr | ₹14 Cr | ₹10 Cr | ₹8.38 Cr | ₹7.12 Cr |
Printing and stationery | ₹10 Cr | ₹7.02 Cr | ₹5.25 Cr | ₹4.35 Cr | ₹5.14 Cr |
Professional and legal fees | ₹169 Cr | ₹88 Cr | ₹49 Cr | ₹31 Cr | ₹64 Cr |
Traveling and conveyance | ₹496 Cr | ₹358 Cr | ₹270 Cr | ₹270 Cr | ₹297 Cr |
Other Administration | ₹143 Cr | ₹105 Cr | ₹58 Cr | ₹65 Cr | ₹75 Cr |
Selling and Distribution Expenses | ₹638 Cr | ₹708 Cr | ₹588 Cr | ₹427 Cr | ₹522 Cr |
Advertisement & Sales Promotion | ₹374 Cr | ₹452 Cr | ₹386 Cr | ₹255 Cr | ₹357 Cr |
Sales Commissions & Incentives | ₹180 Cr | ₹174 Cr | ₹140 Cr | ₹124 Cr | ₹116 Cr |
Freight and Forwarding | ₹84 Cr | ₹82 Cr | ₹61 Cr | ₹47 Cr | ₹49 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹0.28 Cr | ₹0.22 Cr | ₹0.20 Cr | - | - |
Miscellaneous Expenses | ₹151 Cr | ₹121 Cr | ₹107 Cr | ₹159 Cr | ₹59 Cr |
Bad debts /advances written off | ₹4.64 Cr | ₹4.92 Cr | ₹0.55 Cr | ₹0.61 Cr | ₹1.25 Cr |
Provision for doubtful debts | ₹11 Cr | ₹9.65 Cr | ₹1.14 Cr | ₹5.92 Cr | ₹1.12 Cr |
Losson disposal of fixed assets(net) | - | ₹3.74 Cr | ₹3.04 Cr | - | ₹1.28 Cr |
Losson foreign exchange fluctuations | - | - | - | ₹1.03 Cr | ₹0.54 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹136 Cr | ₹103 Cr | ₹102 Cr | ₹151 Cr | ₹55 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹6,848 Cr | ₹5,791 Cr | ₹4,565 Cr | ₹4,427 Cr | ₹4,055 Cr |
Operating Profit (Excl OI) | ₹1,902 Cr | ₹1,991 Cr | ₹1,649 Cr | ₹1,445 Cr | ₹925 Cr |
Other Income | ₹129 Cr | ₹196 Cr | ₹171 Cr | ₹104 Cr | ₹53 Cr |
Interest Received | ₹13 Cr | ₹13 Cr | ₹38 Cr | ₹13 Cr | ₹5.61 Cr |
Dividend Received | ₹0.00 Cr | ₹0.00 Cr | ₹0.42 Cr | ₹4.28 Cr | ₹0.31 Cr |
Profit on sale of Fixed Assets | ₹1.67 Cr | - | - | ₹1.94 Cr | ₹0.66 Cr |
Profits on sale of Investments | - | - | - | ₹35 Cr | ₹30 Cr |
Provision Written Back | ₹4.15 Cr | ₹34 Cr | ₹7.71 Cr | - | - |
Foreign Exchange Gains | ₹10 Cr | ₹8.85 Cr | ₹0.50 Cr | - | - |
Others | ₹100 Cr | ₹140 Cr | ₹124 Cr | ₹50 Cr | ₹17 Cr |
Operating Profit | ₹2,030 Cr | ₹2,187 Cr | ₹1,820 Cr | ₹1,548 Cr | ₹978 Cr |
Interest | ₹46 Cr | ₹60 Cr | ₹21 Cr | ₹23 Cr | ₹44 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹36 Cr | ₹16 Cr | ₹16 Cr | ₹14 Cr | ₹39 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹5.49 Cr | ₹4.02 Cr | ₹1.85 Cr | ₹1.69 Cr | ₹3.94 Cr |
Other Interest | ₹4.23 Cr | ₹40 Cr | ₹3.77 Cr | ₹7.85 Cr | ₹1.18 Cr |
PBDT | ₹1,985 Cr | ₹2,127 Cr | ₹1,799 Cr | ₹1,525 Cr | ₹934 Cr |
Depreciation | ₹326 Cr | ₹167 Cr | ₹119 Cr | ₹99 Cr | ₹69 Cr |
Profit Before Taxation & Exceptional Items | ₹1,659 Cr | ₹1,960 Cr | ₹1,680 Cr | ₹1,426 Cr | ₹865 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹1,671 Cr | ₹1,975 Cr | ₹1,692 Cr | ₹1,438 Cr | ₹875 Cr |
Provision for Tax | ₹362 Cr | ₹522 Cr | ₹399 Cr | ₹382 Cr | ₹264 Cr |
Current Income Tax | ₹332 Cr | ₹451 Cr | ₹395 Cr | ₹408 Cr | ₹269 Cr |
Deferred Tax | ₹41 Cr | ₹49 Cr | ₹2.41 Cr | ₹-33 Cr | ₹-8.80 Cr |
Other taxes | ₹-12 Cr | ₹21 Cr | ₹1.43 Cr | ₹5.87 Cr | ₹4.28 Cr |
Profit After Tax | ₹1,310 Cr | ₹1,453 Cr | ₹1,293 Cr | ₹1,056 Cr | ₹610 Cr |
Extra items | - | - | - | - | - |
Minority Interest | ₹-28 Cr | ₹-19 Cr | ₹-28 Cr | ₹-26 Cr | ₹-32 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹1,282 Cr | ₹1,433 Cr | ₹1,265 Cr | ₹1,030 Cr | ₹579 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹6,735 Cr | ₹5,304 Cr | ₹4,065 Cr | ₹3,408 Cr | ₹2,860 Cr |
Appropriations | ₹8,017 Cr | ₹6,737 Cr | ₹5,331 Cr | ₹4,438 Cr | ₹3,439 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹4.85 Cr | ₹1.80 Cr | ₹27 Cr | ₹248 Cr | ₹31 Cr |
Equity Dividend % | - | - | - | ₹310.00 | ₹445.00 |
Earnings Per Share | ₹32.00 | ₹35.78 | ₹31.59 | ₹25.72 | ₹14.44 |
Adjusted EPS | ₹32.00 | ₹35.78 | ₹31.59 | ₹25.72 | ₹14.44 |
Compare Income Statement of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹83,865.6 Cr | -6.1% | -11.9% | 54.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,470.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹112,990.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,846.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,849.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,742.1 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -6.1% |
-11.9% |
54.1% |
SENSEX | 1.7% |
0.7% |
19.2% |
You may also like the below Video Courses